Methdilazine - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for methdilazine and what is the scope of freedom to operate?
Methdilazine
is the generic ingredient in two branded drugs marketed by Westwood Squibb and Alpharma Us Pharms, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.There are four drug master file entries for methdilazine.
Summary for methdilazine
| US Patents: | 0 |
| Tradenames: | 2 |
| Applicants: | 2 |
| NDAs: | 2 |
| Drug Master File Entries: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 22 |
| Patent Applications: | 3,980 |
| DailyMed Link: | methdilazine at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for methdilazine
US Patents and Regulatory Information for methdilazine
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Westwood Squibb | TACARYL | methdilazine hydrochloride | TABLET;ORAL | 011950-006 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Westwood Squibb | TACARYL | methdilazine | TABLET, CHEWABLE;ORAL | 011950-009 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Westwood Squibb | TACARYL | methdilazine hydrochloride | SYRUP;ORAL | 011950-007 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Alpharma Us Pharms | METHDILAZINE HYDROCHLORIDE | methdilazine hydrochloride | SYRUP;ORAL | 087122-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
